News

News
Filter
FP2020 in the Media
In the News
Press Releases
Updates
Advocacy & Awareness
Contraceptive Security
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country
Date: 11/23/2017
Source: Devex
Type: FP2020 in the Media
It is increasingly acknowledged that the global gender gap is severe, with major negative economic and social consequences, and that accelerating progress toward gender parity has enormous benefits. Yet progress has been slow. One answer is collaborations — partnerships for parity — but they have to be put together carefully if they are to be effective. Research by the McKinsey Global Institute...
Date: 11/13/2017
Type: Updates
On July 11, 2017, policymakers, donors, and advocates from around the world gathered at the Family Planning Summit in London, UK, to discuss efforts to reach our Family Planning 2020 goals and ensure that more women and girls around the world are able to plan their families and their futures. Watch highlights from this landmark event here. 
Date: 11/12/2017
Source: CNN Philippines
Type: In the News
The Food and Drug Administration (FDA) on Sunday released a list of 51 contraceptives which will be re-certified as safe and non-abortifacient, paving the way for the implementation of one of the key measures of the Reproductive Health Law. This effectively lifts the temporary restraining order issued by the Supreme Court in 2015, and allows the Health Department to distribute over 200,000...
Date: 11/12/2017
Source: Rappler
Type: In the News
The Food and Drug Administration (FDA) has certified that contraceptive implant brands Implanon and Implanon NXT are non-abortifacients or do not cause abortion. The FDA on Sunday, November 12, released the results of its re-certification process of all 51 contraceptives covered by the two-year-old temporary restraining order (TRO) issued by the Supreme Court (SC) against the Reproductive Health...
Date: 11/12/2017
Source: International-Inquirer.net
Type: In the News
The 51 contraceptive products, including the controversial Implanon and Implanon NXT, that were covered by the temporary restraining order (TRO) of the Supreme Court, have been determined to be non-abortifacient, or cannot cause abortion, by the Food and Drug Administration (FDA). In Advisory No. 2017-302 dated Nov. 11, 2017, the FDA said it has already concluded the re-evaluation of the 51...
Can we help you find something?
Advocacy & Awareness
Contraceptive Security
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country